Arrow-right Camera

The Spokesman-Review Newspaper The Spokesman-Review

Monday, November 11, 2019  Spokane, Washington  Est. May 19, 1883
Cloudy 36° Cloudy


Everything tagged

Sort by:

Stories tagged: epipen

UPDATED: Thu., Dec. 6, 2018

Drugmaker to sell cheaper generic rival to EpiPen injectors

Sandoz will sell a pair of injectors, under the name Symjepi, for $250 without insurance.

UPDATED: Sun., Sept. 24, 2017

Idaho getting $483,000 under settlement with EpiPen maker

Idaho is getting roughly $483,000 from EpiPen maker Mylan as part of a multi-state settlement.

UPDATED: Fri., Sept. 8, 2017

EpiPen maker failed to investigate product failures associated with patient deaths, FDA says

The makers of the EpiPen failed to properly investigate more than 100 complaints that the device misfired during life-threatening emergencies — including situations in which patients later died, according to …

UPDATED: Thu., Aug. 17, 2017

Mylan’s EpiPen settlement on defrauding Medicaid gets finalized

Mylan’s $465 million settlement of a U.S. case that claimed the drugmaker defrauded taxpayers by misclassifying its allergy-shot EpiPen product as a generic drug was finalized by the Justice Department.

UPDATED: Thu., June 15, 2017

FDA approves new, cheaper rival to EpiPen allergy shot

The agency on Thursday approved Adamis Pharmaceuticals Corp.’s product, which should go on sale later this year.

Legislation needed to curb drug-price hikes

Recent legislation in the U.S. Senate and in the Washington Legislature may eventually shine a brighter light on pricing practices.

UPDATED: Thu., Jan. 12, 2017

CVS selling rival, generic version of EpiPen at sixth of its price

CVS is now selling a rival, generic version of Mylan’s EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated …

Consumer Confidential: Insulin price hikes aren’t sweet

A key feature of Republican plans to replace Obamacare is allowing market forces to boost innovation and competition among health care providers. “Unleashing the power of choice and competition is …

Mylan releases a half-priced generic version of EpiPen

Months after promised, Mylan launched a half-priced authorized generic of EpiPen, the lifesaving allergy injection that drew political ire for its dramatic price increases.

EpiPen manufacturer will be a no-show at Senate hearing

Senate Judiciary Chairman Charles Grassley says pharmaceutical company Mylan is declining to testify at his committee’s hearing next week on a settlement between the company and the Justice Department over …

Martin Shkreli debuts secret Wu-Tang album after Trump win

President-elect Donald Trump’s victory Tuesday has prompted embattled pharmaceutical executive Martin Shkreli to publicly debut some songs off the one-of-a-kind Wu-Tang Clan album he bought for $2 million last year.

Mylan’s EpiPen profits are 60 percent more than it told Congress, report says

Lawmakers were skeptical last week when Mylan chief executive Heather Bresch said that the company made only $100 in profit for a two-pack of EpiPens. During a House hearing, Bresch …

Mylan CEO defends EpiPen cost to angry lawmakers

Outraged Republican and Democratic lawmakers on Wednesday grilled the head of pharmaceutical company Mylan about the significant cost increase of its lifesaving EpiPens and the profits for a company with …

New York attorney general investigates EpiPen manufacturer

New York’s attorney general says his office is investigating Mylan Pharmaceuticals, which has been criticized for steep price increases for its emergency allergy treatment EpiPen.

Gary Crooks: U.S. health care not a bargain

The reality is that patients in other countries are charged less for health care services and drugs across the board, because their governments make it so.

Opinion: EpiPen price gouging pales in comparison to Mylan’s treatment of America

Mylan, the giant pharmaceutical company, has gotten tons of grief lately for jacking up the price of its lifesaving EpiPen. What you might not know is that Mylan moved it …

An EpiPen saved my life last week, Spokane resident writes

Spokane resident Zach Shallbetter wrote this opinion column about his reliance on EpiPens and his opinion of their dramatic price increase. It originally appeared on the website Medium.

Mylan launching cheaper, generic version of EpiPen

Mylan will start selling a cheaper version of its EpiPen after absorbing waves of criticism over a list price for the emergency allergy treatment that has grown to $608 for …

Outside View: Another black eye for Big Pharma

The following editorial from the Sacramento Bee does not necessarily reflect the view of The Spokesman-Review’s editorial board. It’s bad enough that the price of life-saving EpiPens has exploded from …

Spiked EpiPen prices has lawmakers calling for FTC investigation

Lawmakers are demanding more information on why the price for lifesaving EpiPens has skyrocketed.